Cara Therapeutics | CARA - Current Liabilities

Stock Price
3.39
Daily Change
0.17 5.28%
Monthly
-1.45%
Yearly
-80.60%
Q2 Forecast
2.82

Cara Therapeutics reported $11.04M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 277.11M 79.47M Dec/2025
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Assertio Holdings USD 166.78M 34.25M Sep/2025
Cara Therapeutics USD 11.04M 362K Sep/2025
Cassava Sciences USD 43.83M 4.21M Dec/2025
Chugai Pharma JPY 411.08B 143.65B Dec/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
CSL USD 4.61B 207M Dec/2025
Grifols EUR 2.37B 156.97M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Neurocrine Biosciences USD 743.4M 105.4M Dec/2025
Pacira USD 120.59M 13.51M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
RedHill Biopharma USD 22.29M 64K Jun/2025
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
Vanda Pharmaceuticals USD 145.16M 27.29M Dec/2025